Immunomodulatory antibodies for the treatment of lymphoma: Report on the CALYM Workshop

Houot Roch; Gaulard Philippe; Schreiber Robert; Mellman Ira; Lambotte Olivier; Coulie Pierre G.; Fest Thierry; Korman Alan; Levy Ronald; Shipp Margaret; Tarte Karin; Kohrt Holbrook; Marabelle Aurelien; Ansell Stephen; Watier Herve; van Elsas Andrea; Balakumaran Arun; Vargas Frederick Arce; Quezada Sergio A.; Salles Gilles; Olive Daniel

首页> 外文期刊>Oncoimmunology. >Immunomodulatory antibodies for the treatment of lymphoma: Report on the CALYM Workshop

【24h】

Immunomodulatory antibodies for the treatment of lymphoma: Report on the CALYM Workshop

机译：治疗淋巴瘤的免疫调节抗体：Calym Workshop的报告

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

In November 2015, the CALYM Carnot Institute held a 2-d workshop to discuss the current and future development of immunomodulatory antibodies for the treatment of lymphoma. Highlights from the workshop are presented in this article.

机译：2015年11月，Calym Carnot Institute举行了一名二级研讨会，讨论了治疗淋巴瘤的免疫调节抗体的当前和未来发展。本文提出了研讨会的亮点。

著录项

来源
《Oncoimmunology.》 |2016年第7期|共8页
作者
Houot Roch; Gaulard Philippe; Schreiber Robert; Mellman Ira; Lambotte Olivier; Coulie Pierre G.; Fest Thierry; Korman Alan; Levy Ronald; Shipp Margaret; Tarte Karin; Kohrt Holbrook; Marabelle Aurelien; Ansell Stephen; Watier Herve; van Elsas Andrea; Balakumaran Arun; Vargas Frederick Arce; Quezada Sergio A.; Salles Gilles; Olive Daniel;
展开▼
作者单位

CHU Rennes Dept Hematol Rennes France;

Univ Paris Est CHU Henri Mondor Inserm U955 Dept Pathol Creteil France;

Washington Univ Dept Pathol &

Immunol St Louis MO USA;

Genentech Inc San Francisco CA 94080 USA;

Univ Paris 11 Hosp Kremlin Bicetre Dept Clin Immunol &

Internal Med Orsay France;

Catholic Univ Louvain de Duve Inst Brussels Belgium;

CHU Rennes Inserm U917 Rennes France;

Bristol Myers Squibb Redwood City CA USA;

Stanford Sch Med Stanford CA USA;

Dana Farber Canc Inst Boston MA 02115 USA;

CHU Rennes Inserm U917 Rennes France;

Stanford Sch Med Dept Med Stanford CA USA;

Gustave Roussy Canc Campus Villejuif France;

Mayo Clin Div Hematol Rochester MN USA;

Univ Tours CHRU Tours Tours France;

Aduro Biotech Europe Oss Netherlands;

Merck &

Co Inc Clin Res Oncol Kenilworth NJ USA;

UCL UCL Canc Inst London England;

UCL UCL Canc Inst London England;

Univ Lyon 1 Hosp Civils Lyon INSERM 1052 Dept Hematol Lyon France;

Aix Marseille Univ Inst Paoli Calmettes Inserm UMR 1068 Marseille France;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词
Immunomodulation; immunotherapy; lymphoma; programmed cell death 1 ligand 1; programmed cell death 1 receptor;

机译：免疫调节;免疫疗法;淋巴瘤;编程的细胞死亡1配体1;编程的细胞死亡1受体;

相似文献

外文文献
中文文献
专利

1. 复发性晚期滤泡性淋巴瘤的IDEC-C2B8(利妥希玛)抗CD20抗体治疗:德国低度恶性淋巴瘤研究组Ⅱ期研究结果 [J] . 李登举, 唐锦治中德临床肿瘤学杂志（英文版） . 2001,第004期
2. Immunomodulatory antibodies for the treatment of lymphoma: Report on the CALYM Workshop [J] . Houot Roch, Gaulard Philippe, Schreiber Robert, Oncoimmunology. . 2016,第7期

机译：治疗淋巴瘤的免疫调节抗体：Calym Workshop的报告
3. Malignant Lymphoma. A Series of Workshops on the Biology of Human Cancer. Report No. 7 IUCC Technical Reports Series [J] . J H Scarffe British Journal of Cancer . 1980,第3期

机译：恶性淋巴瘤。一系列人类癌症生物学讲习班。第7号报告IUCC技术报告系列
4. Full recovery of agrypnia associated with anti-Lgi1 antibodies encephalitis under immunomodulatory treatment: A case report with sequential polysomnographic assessment [J] . Peter-DerexL., DevicP., RogemondV., Sleep medicine . 2012,第5期

机译：免疫调节治疗可完全恢复抗Lgi1抗体性脑炎相关的腹痛：连续多导睡眠图评估的病例报告
5. Development of Single Domain Antibodies for Diagnosis and Treatment of Naturally Occurring Canine Lymphoma: An Animal Model for Human Non-Hodgkin Lymphoma [C] . Joana Dias, Solange Gil, Belmira Carrapico, PEGS . 2015

机译：天然犬淋巴瘤诊断和治疗单结构域抗体的发展：人非霍奇金淋巴瘤的动物模型
6. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
7. Immunomodulatory antibodies for the treatment of lymphoma: Report on the CALYM Workshop [O] . Roch Houot, Philippe Gaulard, Robert Schreiber, 2016

机译：用于淋巴瘤治疗的免疫调节抗体：CALYM Workshop上的报告
8. Immunomodulatory antibodies for the treatment of lymphoma: Report on the CALYM Workshop [O] . Houot, Roch, Gaulard, P., Schreiber, R., 2016

机译：用于淋巴瘤治疗的免疫调节抗体：CALYM Workshop上的报告

Immunomodulatory antibodies for the treatment of lymphoma: Report on the CALYM Workshop

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅